Lotus Eye Hospital passes all AGM resolutions; scrutinizer report released
- All four resolutions at Lotus Eye Hospital's 29th AGM passed with requisite majorities
- Adoption of FY26 financial statements received 99.39% votes in favour
- Re-appointment of Dr. Kavetha Sundaramoorthy approved with 81.27% support
- Remuneration revision for MD Sangeetha Sundaramoorthy passed with 76.43% votes

*this image is generated using AI for illustrative purposes only.
Lotus Eye Hospital and Institute Limited concluded its 29th Annual General Meeting on September 23, 2026, with all four proposed resolutions passing with requisite majorities. The Consolidated Scrutinizer's Report was submitted on September 24, 2026, confirming the voting outcomes for the meeting held via Video Conferencing/Other Audio Visual Means (VC/OAVM).
Meeting proceedings
The meeting commenced at 4:00 pm and concluded at 4:25 pm. Dr. Kavetha Sundaramoorthy, Chairperson, presided over the session. All directors of the company attended the meeting. The requisite quorum was present, allowing the Chairperson to call the meeting to order.
The Managing Director briefed shareholders on the services provided by the company and other significant aspects of its business operations. Subsequently, the Chief Financial Officer presented the financial highlights for the financial year 2025-26 (FY26).
Governance and audit status
Key governance updates included:
- The Statutory Auditors issued an unmodified audit report for FY26.
- Qualifications contained in the Secretarial Audit Report were duly addressed by the Management.
- Appropriate responses to these qualifications were provided in the Board's Report.
- The items of business contained in the AGM Notice were taken as read with shareholder permission.
Voting results summary
The e-voting facility remained open for a further period of 30 minutes after the discussion concluded. The following table summarizes the voting outcomes for the four resolutions passed during the 29th AGM:
| Resolution | Type | Description | Votes For (%) | Votes Against (%) | Result |
|---|---|---|---|---|---|
| Item No. 1 | Ordinary | Adoption of FY26 Financial Statements | 99.39% | 0.61% | Passed |
| Item No. 2 | Ordinary | Re-appointment of Dr. Kavetha Sundaramoorthy | 81.27% | 18.73% | Passed |
| Item No. 3 | Ordinary | Revision in remuneration of Ms. Sangeetha Sundaramoorthy | 76.43% | 23.57% | Passed |
| Item No. 4 | Special | Continuation of remuneration to Dr. K.S. Ramalingam | 94.54% | 5.46% | Passed |
Shareholder engagement
Shareholders were given an opportunity to speak and raise queries during the meeting. Out of three shareholders who registered to speak, only one was present. The questions raised by this shareholder were duly addressed by the Chief Financial Officer.
The Scrutinizer, P. Eswaramoorthy of P. Eswaramoorthy and Company, Company Secretaries, confirmed that the remote e-voting period ran from September 20, 2026, to September 22, 2026. Shareholders holding shares as of the cut-off date, September 16, 2026, were entitled to vote. The electronic voting system provided by Central Depository Services (India) Limited (CDSL) ensured that no shareholder voted more than once.
The Chairperson thanked all shareholders for their participation before declaring the meeting closed. The scrutinizer's records remain in safe custody until the minutes are approved and signed.
Historical Stock Returns for Lotus Eye Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.53% | +0.37% | +3.41% | +5.30% | -6.55% | 0.0% |
How might the 18.73% dissenting vote against Dr. Kavetha Sundaramoorthy's re-appointment influence future board composition or governance reforms at Lotus Eye Hospital?
What specific strategic initiatives or capital expenditures are outlined in the FY26 financial highlights that could drive growth for the company in the coming fiscal year?
Given the Secretarial Audit qualifications were addressed, what ongoing compliance measures will the management implement to prevent recurrence in the FY27 audit cycle?


































